the investigators will follow up after patients with neuroendocrine tumors who undergo PRRT treatment and evaluate the response for treatment using PET/CT with different tracers
patients with suspected or biopsy proven NET will undergo imaging using a Combination of 18F- FDG , 18F-DOPA and 68Ga-DOTATATE PET/CT before the stat of PRRT . after two cycles of treatment another two PET/CT are done using 18F- FDG and 18F-DOPA and about 6-8 weeks from last treatment the patient will undergo PET/CT using 18F-DOPA .
Study Type
OBSERVATIONAL
Enrollment
80
Sheba Medical Center
Ramat Gan, Israel
RECRUITINGNumber of participants with good response to Peptide Receptor Radionuclide Therapy (PRRT)
patients who have clinical and radiological improvement (using RECIST CRITERIA )
Time frame: 7 months
Number of participants with no response to Peptide Receptor Radionuclide Therapy (PRRT) treatment
patients who have no clinical and radiological improvement or worsening in clinical condition or radiologic findings (RECIST )
Time frame: 7 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.